Dementias Enrolling by Invitation Phase 1 Trials for Bosutinib (DB06616)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Enrolling by Invitation1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02921477Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative DementiasTreatment